EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Béatrice DULY-BOUHANICK •  chercheure



2023

  1. Costa N, Mounie M, Gombault-Datzenko E, Boulestreau R, Cremer A, Delchier MC, Gosse P, Lagarde S, Lepage B, Molinier L, Papadopoulos P, Trillaud H, Rousseau H, Bouhanick B. Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy. Cardiovasc Intervent Radiol. 2023 Jan;46(1):89-97. doi: 10.1007/s00270-022-03295-9.

2022

  1. Bouhanick B, Brusq C, Bongard V, Tessier S, Montastruc JL, Senard JM, Montastruc F, Herin F. Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France. J Hum Hypertens. 2022 Jun;36(6):580-581. doi: 10.1038/s41371-021-00634-0.
     
  2. Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V. Prevention of risks associated with inappropriate use/unnecessary consumption of medicines. Therapie. 2022 Jan-Feb;77(1):79-88. doi: 10.1016/j.therap.2022.01.003.
     
  3. Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V. Prévention des risques liés à un usage inapproprié/consommation inutile des médicaments. Therapie. 2022 Jan-Feb;77(1):69-78. French. doi: 10.1016/j.therap.2021.12.020.

2021

  1. Arnaud C, Boulanger M, Lorthioir A, Amar L, Azarine A, Boyer L, Chatellier G, Di Monaco S, Jeunemaitre X, Kastler A, Mousseaux E, Oppenheim C, Thony F, Persu A, Olin JW, Azizi M, Touzé E; ARCADIA Co‐investigators † (Duly-Bouhanick B collaborator). Male Sex Is Associated With Cervical Artery Dissection in Patients With Fibromuscular Dysplasia. J Am Heart Assoc. 2021 Jun;10(11):e018311. doi: 10.1161/JAHA.120.018311.
     
  2. Bouhanick B, Cracowski JL, Faillie JL. DPP-4 inhibitors and severe course of illness in patients with COVID-19. Therapie. 2021 Jul-Aug;76(4):359-360. doi: 10.1016/j.therap.2021.01.051.
     
  3. Bouhanick B, Delchier MC, Lagarde S, Boulestreau R, Conil C, Gosse P, Rousseau H, Lepage B, Olivier P, Papadopoulos P, Trillaud H, Cremer A; ADERADHTA group. Radiofrequency ablation for adenoma in patients with primary aldosteronism and hypertension: ADERADHTA, a pilot study. J Hypertens. 2021 Apr 1;39(4):759-765. doi: 10.1097/HJH.0000000000002708.
     
  4. Bouhanick B, Montastruc F, Tessier S, Brusq C, Bongard V, Senard JM, Montastruc JL, Herin F. Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal. Eur J Clin Pharmacol. 2021 Dec;77(12):1937-1938. doi: 10.1007/s00228-021-03197-8.
     
  5. Bouhanick B, Sosner P, Brochard K, Mounier-Véhier C, Plu-Bureau G, Hascoet S, Ranchin B, Pietrement C, Martinerie L, Boivin JM, Fauvel JP, Bacchetta J. Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension. Front Pediatr. 2021 Jul 7;9:680803. doi: 10.3389/fped.2021.680803.

2020

  1. Alexandre J, Cracowski JL, Richard V, Bouhanick B; ‘Drugs, COVID-19' working group of the French Society of Pharmacology, Therapeutics. Renin-angiotensin-aldosterone system and COVID-19 infection. Ann Endocrinol (Paris). 2020;81(2-3):63‐67. doi:10.1016/j.ando.2020.04.005.
     
  2. Alexandre J, Cracowski JL, Richard V, Bouhanick B; French Society of Pharmacology and Therapeutics (SFPT). Drugs acting on renin angiotensin system and use in ill patients with COVID-19. Therapie. 2020 Jul-Aug;75(4):319-325. doi: 10.1016/j.therap.2020.05.009.
     
  3. Bouhanick B, Delchier MC, Lagarde S, Boulestreau R, Conil C, Gosse P, Rousseau H, Lepage B, Olivier P, Papadopoulos P, Trillaud H, Cremer A; ADERADHTA group*. Radiofrequency ablation for adenoma in patients with primary aldosteronism and hypertension: ADERADHTA, a pilot study. J Hypertens. 2020 Nov 13. doi: 10.1097/HJH.0000000000002708.
     
  4. Bouhanick B, Cracowski JL, Faillie JL; French Society of Pharmacology and Therapeutics (SFPT). Diabetes and COVID-19 [published online ahead of print, 2020 May 15]. Therapie. 2020;S0040-5957(20)30095-0. doi:10.1016/j.therap.2020.05.006.
     
  5. Larrouquere L, Gabin M, Poingt E, Mouffak  A , Hlavaty  A, Lepelley  M, Khouri  C, Bellier  A, Alexandre J, Bedouch  P, Bertoletti  L, Bordet  R, Bouhanick  B, Jonville-Bera  AP, Laporte  S, Le Jeunne  C, Letinier  L, Micallef  J, Naudet  F, Roustit  M, Molimard  M, Richard  V, Cracowski  JL, Société Française de Pharmacologie et de Thérapeutique, Hôpital Bretonneau, Tours, France Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic [published online ahead of print, 2020 May 11]. Fundam Clin Pharmacol. 2020;10.1111/fcp.12564. doi:10.1111/fcp.12564.
     
  6. Meyrignac O, Arcis É, Delchier MC, Mokrane FZ, Darcourt  J, Rousseau  H, Bouhanick  B. Impact of cone beam - CT on adrenal vein sampling in primary aldosteronism. Eur J Radiol. 2020;124:108792. doi:10.1016/j.ejrad.2019.108792.

2019
 

  • Bouhanick B, Blacher J, Huyghe E, et al. Dysfonction érectile et traitement antihypertenseur : impact des différentes classes thérapeutiques et conduite à tenir à l’égard du traitement [Sexual dysfunction and antihypertensive treatment: Involvement of the different therapeutic classes and what to do about the treatment of hypertension]. Presse Med. 2019 ; 48(11 Pt 1):1222–1228. doi:10.1016/j.lpm.2019.05.029.
     
  • Bouhanick B, Fonquernie P, Bedue I, Schavgoulidze A, Gandia P. Pourquoi, comment et où dose-t-on les antihypertenseurs en 2019 ? [Assessment for antihypertensive drug intake: How, where and when?]. Therapie. 2019;74(6):651–664. doi:10.1016/j.therap.2019.05.002.
     
  • Bouhanick B, Vaïsse B, Schavgoulidze A, Gandia P. Dosage des médicaments antihypertenseurs en France en 2019 et observance [Assessment for antihypertensive drug intake in France in 2019 and adherence]. Presse Med. 2019 Dec;48(12):1520-1526. doi: 10.1016/j.lpm.2019.08.009.
     
  • Carpentier C, Dubois S, Mohammedi K, Belhatem N, Bouhanick B, Rohmer V, Briet C, Bumbu A, Hadjadj S, Roussel R, Potier L, Velho G, Marre M. Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients. Nephrol Dial Transplant. 2019. 34 (10), 1731-1738. doi: 10.1093/ndt/gfy197.
     
  • Hamdidouche I, Gosse P, Cremer A, Lorthioir A, Delsart P, Courand PY, Denolle T, Halimi JM, Girerd X, Ormezzano O, Rossignol P, Pereira H, Azizi M; DENERHTN Investigators (Bouhanick B collaborator). Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study.Hypertension.2019;74(5):1096‐1103. doi:10.1161/HYPERTENSIONAHA.119.13520
     
  • Rouch L, Cestac P, Hanon O, Ruidavets JB, Ehlinger V, Gentil C, Cool C, Helmer C, Dartigues JF, Bouhanick B, Chamontin B, Sallerin B, Vellas B, Marquié JC, Esquirol Y, Andrieu S. Blood pressure and cognitive performances in middle-aged adults: the Aging, Health and Work longitudinal study. J Hypertens. 2019;37(6):1244–1253. doi:10.1097/HJH.0000000000002013.
     
  • Rouch L, Cestac P, Hanon O, Ruidavets JB, Ehlinger V, Gentil C, Cool C, Helmer C, Dartigues JF, Bouhanick B, Chamontin B, Sallerin B, Vellas B, Marquié JC, Esquirol Y, Andrieu S. Blood pressure and cognitive performances in middle-aged adults: the Aging, Health and Work longitudinal study. J Hypertens. 2019 Jun;37(6):1244-1253. doi: 10.1097/HJH.0000000000002013.
     
  • Sabatier P, Amar J, Montastruc F, Rousseau V, Chebane L, Bouhanick B, Montastruc JL. Breast cancer and spironolactone: an observational postmarketing study. Eur J Clin Pharmacol. 2019 Nov;75(11):1593-1598. doi: 10.1007/s00228-019-02740-y.